home-banner
Home / Learn / Precision Medicine / Immunotherapy

Immunotherapy

As immunotherapy for cancer continues to evolve—so has the Association of Community Cancer Centers—adapting to meet the changing needs of the oncology community.

The ACCC Immuno-Oncology Institute is the only initiative dedicated to educating multidisciplinary teams to go beyond a clinical understanding of IO and tackle real-world implementation issues. With the care of patients on immunotherapies now extending beyond the cancer team, the ACCC Immuno-Oncology Institute is at the forefront of developing critical education to empower healthcare professionals across care delivery settings.

Under the guidance of the IO Institute Executive Committee, multispecialty Working Groups were established to focus on Big Data, Telemedicine, Care Coordination and Communication, and Training and Education. IO Working Groups members share their expertise, knowledge, and forward-looking perspectives to provide a framework for developing proactive strategies for effective delivery of these new and emerging therapies.

For more information on this project, please contact the ACCC Provider Education department.

Featured Publication

Immuno-Oncology in 2021: Committed to the Cutting Edge of CareDownload

Telemedicine & Virtual Navigation

Cancer Buzz Podcasts

From the ACCCBuzz Blog

  • Cell-culture-test-in-laboratory-768x512
    Must-Listen Podcasts on Precision Medicine
    December 13, 2021
    While precision medicine in cancer care is becoming more widespread, its rapid evolution in oncology requires ongoing discussion. ACCC’s podcast, CANCER BUZZ, features lively expert discussions about emergent issues in cancer care. Here we highlight some of those podcasts.
  • IO Institute 385 x 247 (1)
    ACCC’s Precision Medicine Tools Help Guide Survivorship Care
    December 02, 2021
    Cancer has become the focus of some of the most promising precision medicine applications available today. The evolution of immunotherapy treatment for patients with cancer has given rise to a new class of cancer survivors whose novel experiences with these treatments require new tools and resources.
  • Sigrun Hallmeyer pic
    June Is Cancer Immunotherapy Month
    June 25, 2020
    In recognition of Cancer Immunotherapy Month, ACCCBuzz talked to Sigrun Hallmeyer, MD, the chair of the ACCC Immuno-Oncology Institute’s Executive Committee.